Table of Contents 1 Market Overview 1.1 Postmenopausal Vaginal Atrophy Treatment Introduction 1.2 Market Analysis by Type 1.2.1 Creams 1.2.2 Tablets 1.2.3 Patches 1.2.4 Rings 1.3 Market Analysis by Applications 1.3.1 Topical Estrogen 1.3.2 Systemic Estrogen 1.3.3 Non-hormonal Therapy 1.4 Market Analysis by States 1.4.1 California Status and Prospect (2012-2022) 1.4.2 Texas Status and Prospect (2012-2022) 1.4.3 New York Status and Prospect (2012-2022) 1.4.4 Florida Status and Prospect (2012-2022) 1.4.5 Illinois Status and Prospect (2012-2022) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Pfizer 2.1.1 Profile 2.1.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications 2.1.2.1 Type 1 2.1.2.2 Type 2 2.1.3 Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.1.4 Business Overview 2.1.5 Pfizer News 2.2 Allergan 2.2.1 Profile 2.2.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications 2.2.2.1 Type 1 2.2.2.2 Type 2 2.2.3 Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2.4 Business Overview 2.2.5 Allergan News 2.3 Shionogi 2.3.1 Profile 2.3.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications 2.3.2.1 Type 1 2.3.2.2 Type 2 2.3.3 Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3.4 Business Overview 2.3.5 Shionogi News 2.4 Novo Nordisk 2.4.1 Profile 2.4.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications 2.4.2.1 Type 1 2.4.2.2 Type 2 2.4.3 Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4.4 Business Overview 2.4.5 Novo Nordisk News 2.5 Teva Pharmaceutical 2.5.1 Profile 2.5.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications 2.5.2.1 Type 1 2.5.2.2 Type 2 2.5.3 Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5.4 Business Overview 2.5.5 Teva Pharmaceutical News 2.6 Bayer. 2.6.1 Profile 2.6.2 Postmenopausal Vaginal Atrophy Treatment Type and Applications 2.6.2.1 Type 1 2.6.2.2 Type 2 2.6.3 Bayer. Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6.4 Business Overview 2.6.5 Bayer. News 3 United States Postmenopausal Vaginal Atrophy Treatment Market Competition, by Manufacturer 3.1 United States Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Manufacturer (2016-2017) 3.2 United States Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Manufacturer (2016-2017) 3.3 United States Postmenopausal Vaginal Atrophy Treatment Price by Manufacturers (2016-2017) 3.4 Market Concentration Rate 3.4.1 Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share 3.4.2 Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share 3.5 Market Competition Trend 4 United States Postmenopausal Vaginal Atrophy Treatment Market Analysis by States 4.1 United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by States 4.2 United States Postmenopausal Vaginal Atrophy Treatment Sales by States (2012-2017) 4.3 United States Postmenopausal Vaginal Atrophy Treatment Revenue (Value) by States (2012-2017) 5 United States Market Segmentation Postmenopausal Vaginal Atrophy Treatment by Type 5.1 United States Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Market Share by Type (2012-2017) 5.1.1 United States Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type (2012-2017) 5.1.2 United States Postmenopausal Vaginal Atrophy Treatment Revenue and Market Share by Type (2012-2017) 5.2 Creams Sales Growth and Price 5.2.1 United States Creams Sales Growth (2012-2017) 5.2.2 United States Creams Price (2012-2017) 5.3 Tablets Sales Growth and Price 5.3.1 United States Tablets Sales Growth (2012-2017) 5.3.2 United States Tablets Price (2012-2017) 5.4 Patches Sales Growth and Price 5.4.1 United States Patches Sales Growth (2012-2017) 5.4.2 United States Patches Price (2012-2017) 5.5 Rings Sales Growth and Price 5.5.1 United States Rings Sales Growth (2012-2017) 5.5.2 United States Rings Price (2012-2017) 6 United States Market Segmentation Postmenopausal Vaginal Atrophy Treatment by Application 6.1 United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017) 6.2 Topical Estrogen Sales Growth (2012-2017) 6.3 Systemic Estrogen Sales Growth (2012-2017) 6.4 Non-hormonal Therapy Sales Growth (2012-2017) 7 California Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers 7.1 California Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017) 7.2 California Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type 7.3 California Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) 8 New York Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers 8.1 New York Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017) 8.2 New York Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type 8.3 New York Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) 9 Texas Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers 9.1 Texas Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017) 9.2 Texas Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type 9.3 Texas Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) 10 Florida Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers 10.1 Florida Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017) 10.2 Florida Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type 10.3 Florida Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) 11 Illinois Postmenopausal Vaginal Atrophy Treatment Sales, Revenue, by Type, Application and Manufacturers 11.1 Illinois Postmenopausal Vaginal Atrophy Treatment Revenue, Sales and Growth Rate (2012-2017) 11.2 Illinois Postmenopausal Vaginal Atrophy Treatment Sales and Market Share by Type 11.3 Illinois Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) 12 Postmenopausal Vaginal Atrophy Treatment Market Forecast (2017-2022) 12.1 United States Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Growth Rate (2017-2022) 12.2 Postmenopausal Vaginal Atrophy Treatment Market Forecast by States (2017-2022) 12.3 Postmenopausal Vaginal Atrophy Treatment Market Forecast by Type (2017-2022) 12.4 Postmenopausal Vaginal Atrophy Treatment Market Forecast by Application (2017-2022) 13 Postmenopausal Vaginal Atrophy Treatment Manufacturing Cost Analysis 13.1 Postmenopausal Vaginal Atrophy Treatment Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Price Trend of Key Raw Materials 13.1.3 Key Suppliers of Raw Materials 13.1.4 Market Concentration Rate of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.2.1 Raw Materials 13.2.2 Labor Cost 13.2.3 Manufacturing Expenses 13.3 Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Treatment 14 Industrial Chain, Sourcing Strategy and Downstream Buyers 14.1 Postmenopausal Vaginal Atrophy Treatment Industrial Chain Analysis 14.2 Upstream Raw Materials Sourcing 14.3 Raw Materials Sources of Postmenopausal Vaginal Atrophy Treatment Major Manufacturers in 2016 14.4 Downstream Buyers 15 Sales Channel, Distributors, Traders and Dealers 15.1 Sales Channel 15.1.1 Direct Marketing 15.1.2 Indirect Marketing 15.1.3 Marketing Channel Future Trend 15.2 Distributors, Traders and Dealers 16 Research Findings and Conclusion 17 Appendix 17.1 Methodology 17.2 Analyst Introduction 17.3 Data Source

List of Tables and Figures Figure Postmenopausal Vaginal Atrophy Treatment Picture Table Product Specifications of Postmenopausal Vaginal Atrophy Treatment Figure United States Sales Market Share of Postmenopausal Vaginal Atrophy Treatment by Types in 2016 Table Types of Postmenopausal Vaginal Atrophy Treatment Figure Creams Picture Table Major Manufacturers of Creams Figure Tablets Picture Table Major Manufacturers of Tablets Figure Patches Picture Table Major Manufacturers of Patches Figure Rings Picture Table Major Manufacturers of Rings Table United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Applications in 2016 Table Applications of Postmenopausal Vaginal Atrophy Treatment Figure Topical Estrogen Picture Figure Systemic Estrogen Picture Figure Non-hormonal Therapy Picture Figure California Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022) Figure Texas Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022) Figure New York Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022) Figure Florida Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022) Figure Illinois Postmenopausal Vaginal Atrophy Treatment Revenue (Million USD) and Growth Rate (2012-2022) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Postmenopausal Vaginal Atrophy Treatment Type and Applications Table Pfizer Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Allergan Basic Information, Manufacturing Base and Competitors Table Allergan Postmenopausal Vaginal Atrophy Treatment Type and Applications Table Allergan Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Shionogi Basic Information, Manufacturing Base and Competitors Table Shionogi Postmenopausal Vaginal Atrophy Treatment Type and Applications Table Shionogi Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Novo Nordisk Basic Information, Manufacturing Base and Competitors Table Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Type and Applications Table Novo Nordisk Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors Table Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Type and Applications Table Teva Pharmaceutical Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bayer. Basic Information, Manufacturing Base and Competitors Table Bayer. Postmenopausal Vaginal Atrophy Treatment Type and Applications Table Bayer. Postmenopausal Vaginal Atrophy Treatment Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Manufacturer (2016-2017) Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2016 Figure United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Manufacturer in 2017 Table United States Postmenopausal Vaginal Atrophy Treatment Revenue by Manufacturer (2016-2017) Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2015 Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by Manufacturer in 2016 Table United States Postmenopausal Vaginal Atrophy Treatment Price by Manufacturers (2016-2017) Figure Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2016 Figure Top 3 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2017 Figure Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2016 Figure Top 5 Postmenopausal Vaginal Atrophy Treatment Manufacturer Market Share in 2017 Figure United States Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Sales by States (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Sales Market Share by States (2012-2017) Figure United States 2012 Postmenopausal Vaginal Atrophy Treatment Sales Market Share by States Figure United States 2016 Postmenopausal Vaginal Atrophy Treatment Sales Market Share by States Figure United States Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Revenue by States (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by States (2012-2017) Table United States 2012 Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by States Table United States 2016 Postmenopausal Vaginal Atrophy Treatment Revenue Market Share by States Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Sales Share by Type (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Revenue by Type (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Revenue Share by Type (2012-2017) Figure United States Creams Sales Growth (2012-2017) Figure United States Creams Price (2012-2017) Figure United States Tablets Sales Growth (2012-2017) Figure United States Tablets Price (2012-2017) Figure United States Patches Sales Growth (2012-2017) Figure United States Patches Price (2012-2017) Figure United States Rings Sales Growth (2012-2017) Figure United States Rings Price (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) Table United States Postmenopausal Vaginal Atrophy Treatment Sales Share by Application (2012-2017) Figure United States Topical Estrogen Sales Growth (2012-2017) Figure United States Systemic Estrogen Sales Growth (2012-2017) Figure United States Non-hormonal Therapy Sales Growth (2012-2017) Figure California Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017) Figure California Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017) Table California Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017) Table California Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017) Table California Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) Table California Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017) Figure New York Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017) Figure New York Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017) Table New York Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017) Table New York Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017) Table New York Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) Table New York Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017) Figure Texas Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017) Figure Texas Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017) Table Texas Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017) Table Texas Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017) Table Texas Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) Table Texas Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017) Figure Florida Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017) Figure Florida Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017) Table Florida Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017) Table Florida Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017) Table Florida Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) Table Florida Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017) Figure Illinois Postmenopausal Vaginal Atrophy Treatment Revenue and Growth (2012-2017) Figure Illinois Postmenopausal Vaginal Atrophy Treatment Sales and Growth (2012-2017) Table Illinois Postmenopausal Vaginal Atrophy Treatment Sales by Type (2012-2017) Table Illinois Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Type (2012-2017) Table Illinois Postmenopausal Vaginal Atrophy Treatment Sales by Application (2012-2017) Table Illinois Postmenopausal Vaginal Atrophy Treatment Sales Market Share by Application (2012-2017) Figure United States Postmenopausal Vaginal Atrophy Treatment Sales, Revenue and Growth Rate (2017-2022) Table United States Postmenopausal Vaginal Atrophy Treatment Sales Forecast by States (2017-2022) Table United States Postmenopausal Vaginal Atrophy Treatment Market Share Forecast by States (2017-2022) Table United States Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Type (2017-2022) Table United States Postmenopausal Vaginal Atrophy Treatment Market Share Forecast by Type (2017-2022) Table United States Postmenopausal Vaginal Atrophy Treatment Sales Forecast by Application (2017-2022) Table United States Postmenopausal Vaginal Atrophy Treatment Market Share Forecast by Application (2017-2022) Table Sales Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Postmenopausal Vaginal Atrophy Treatment Figure Manufacturing Process Analysis of Postmenopausal Vaginal Atrophy Treatment Figure Postmenopausal Vaginal Atrophy Treatment Industrial Chain Analysis Table Raw Materials Sources of Postmenopausal Vaginal Atrophy Treatment Major Manufacturers in 2016 Table Major Buyers of Postmenopausal Vaginal Atrophy Treatment Table Distributors/Traders/ Dealers List